Prognostic model for determining the probability of congenital pneumonia in full-term newborns
Journal Title: Здоров`я дитини - Year 2019, Vol 14, Issue 4
Abstract
According to the data of the World Health Organization, pneumonia is one of the leading causes of death in children under five years of age. Objective: to develop a prognostic model to determine the factors associated with the development of congenital pneumonia in full-term newborns. A comprehensive survey of 116 full-term newborns who were in the pediatric Department for newborn children and the Maternity Physiological Department of the State Institution “Republican Scientific and Practical Center “Mother and Child” in the period from 2017 to 2019 was conducted. The study group consisted of 53 healthy full-term newborns with congenital pneumonia, born at the gestational age of 39.50 ± 0.69 weeks, body weight 3337.50 ± 354.42 g and a body length of 52.20 ± 2.13 cm. The control group consisted of 63 healthy full-term babies born at gestational age of 39.30 ± 0.63 weeks, body weight 3417.30 ± 253.82 g and a body length of 52.50 ± 1.57 cm. The survey revealed the most significant factors associated with the development of congenital pneumonia in full-term newborns: from the obstetric-gynecological and somatic history of the mother’s life — spontaneous miscarriage; from the complications of pregnancy — chronic intrauterine fetal hypoxia; the placenta study determined the presence of inflammatory changes in the placenta; clinical manifestations within the first 72 hours of life included respiratory failure. Based on the data obtained, a model with sensitivity equal to 92.5 %, specificity 92.1 % and an area under ROC-curve (AUC) 0.94 ± 0.054, p < 0.001 (95% CI 0.90–0.99). Using a prognostic model, threshold values were calculated: for spontaneous miscarriage — 0.810; chronic intrauterine fetal hypoxia — 0.289; inflammatory changes in the placenta — 0.565; the presence of respiratory failure — 0.928, which at threshold values ≥ 0.56 ROC-curve allows identify a high risk group for the development of congenital pneumonia among full-term newborns.
Authors and Affiliations
A. N. Horiachko, A. V. Sukalo
Keywords
Related Articles
- EP ID EP613558
- DOI 10.22141/2224-0551.14.4.2019.174040
- Views 88
- Downloads 0
Efficacy of the Drug «Horlospas for Children» in Acute Respiratory Diseases, Acute Catarrhal Tonsillopharyngitis in Preschool Children
Local treatment of 30 preschool children suffering from acute respiratory diseases, acute catarrhal tonsillopharyngitis was conducted using the drug Horlospas for Children, which is a metered dose spray containing sea...
Using Recombinant Interferon Alpha-2b in Pediatric Practice
Interferon system is a key element of antiviral defense of the child’s body that etiopathogenetically justifies the use of nasal and rectal formulations of recombinant interferon alfa-2b for the prevention and treatment...
Systemic circulation in children with diet-related diseases
Background. The basic group of diet-related diseases is gastroenterological pathology, obesity, metabolic syndrome and diabetes mellitus. One of the leading mechanisms in the course of these pathologies is an imbalance i...
Etiopathogenetic Therapy of Acute Respiratory Viral Infections in Children
The methods of etiopathogenetic treatment of acute respiratory viral infections in children using recombinant α-2b-interferons are presented in the article.
Clinical case of neonatal acute lymphoblastic leukemia
The article presents a clinical case of neonatal acute lymphoblastic leukemia in a child aged 22 days, with damage to the central nervous system and testicular involvement in the pathological process. The manifestation o...